Edition:
United States

Esperion Therapeutics Inc (ESPR.OQ)

ESPR.OQ on NASDAQ Stock Exchange Global Market

10.86USD
28 Jul 2016
Change (% chg)

$-0.50 (-4.40%)
Prev Close
$11.36
Open
$11.38
Day's High
$11.38
Day's Low
$10.69
Volume
92,741
Avg. Vol
130,682
52-wk High
$82.50
52-wk Low
$9.58

Reports per page
Select Report Title Date Provider Pgs Price
Thomson Reuters Stock Report - Esperion Therapeutics Inc (ESPR-O) 28 Jul 2016 Thomson Reuters Stock Report 12 25.00
ValuEngine Rating and Forecast Report for ESPR 23 Jul 2016 ValuEngine, Inc. 11 25.00
ESPERION THERAPEUTICS INC (ESPR=US) - SHORT AND LONG TERM FORECASTS FOR ACTIVE TRADERS 22 Jul 2016 Pechala's Reports 2 25.00
Esperion Therapeutics Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis. 22 Jul 2016 Reuters Investment Profile 12 20.00
Value Graph: ESPERION THERAPE -- ESPR 21 Jul 2016 Ford Investor Services, Inc. 1 12.00
ESPR.OQ - Event Transcript of Esperion Therapeutics Inc conference call, Jun. 28, 2016 / 4:30PM ET 28 Jun 2016 Thomson Reuters StreetEvents 17 75.00
Esperion Therapeutics, Inc. (ESPR) - Financial Analysis Review 16 May 2016 GlobalData 43 300.00
Thomson Reuters Stock Report - Esperion Therapeutics Inc (ESPR-O) 10 May 2016 Thomson Reuters Stock Report 12 25.00
 
Name Age Since Current Position

Roger Newton

64 Executive Chairman of the Board, Chief Scientific Officer

Timothy Mayleben

55 2012 President, Chief Executive Officer, Director

Narendra Lalwani

62 2014 Chief Operating Officer, Executive Vice President - Research & Development

Mary McGowan

2015 Chief Medical Officer

Scott Braunstein

2015 Director